Bariatric Surgeries Carry Low Perioperative Risks

Follow Drugslib on

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

FRIDAY, Feb. 2, 2024 -- Laparoscopic sleeve gastrectomy (SG) and laparoscopic Roux-en-Y gastric bypass (RYGB) have similarly low perioperative risk among adults with obesity, according to a study published online Jan. 30 in JAMA Network Open.

Suzanne Hedberg, M.D., Ph.D., from University of Gothenburg in Sweden, and colleagues compared perioperative outcomes for 1,735 adult patients undergoing SG (878 individuals) or RYGB (857 individuals) from Oct. 6, 2015, to March 31, 2022, at university, regional, county, or private hospitals in Sweden and Norway.

The researchers found that the mean operating time was significantly shorter in those undergoing SG versus RYGB (47 versus 68 minutes). For both groups, the median postoperative hospital stay was one day. The 30-day readmission rate was also similar between the groups (SG: 3.1 percent; RYGB: 4.0 percent). No deaths were reported at 90 days. The 30-day incidence of any adverse event was also similar in the two groups (SG: 4.6 percent; RYGB: 6.3 percent; odds ratio, 0.71; 95 percent confidence interval, 0.47 to 1.08). Results were similar for serious adverse events (1.7 and 2.7 percent, respectively; odds ratio, 0.63; 95 percent confidence interval, 0.33 to 1.22).

"Among adult patients with obesity undergoing primary bariatric surgery, the perioperative risk should not be a main deciding factor in the choice of method," the authors write.

Several authors disclosed financial ties to industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-02-03 08:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords